ERBB2 and obesity due to melanocortin 4 receptor deficiency: While the literature does not indicate that obesity increases HER2+ breast cancer risk [35], studies have found that an elevated BMI is associated with a worse breast cancer outcome across all subtypes after adjustment for HER2 status [9] and specifically in patients with HER2+/ERα- tumors [36].